Firms

EW Healthcare Partners

EW Healthcare Partners

ewhealthcare.com

Healthcare growth-equity investment firm founded in 1985, formerly known as Essex Woodlands. Its registered investment adviser is Essex Woodlands Management, Inc., with Essex Woodlands Services Co., Inc. as a relying adviser. The firm invests in revenue-generating pharmaceutical, medical-technology and technology-enabled healthcare businesses in the United States and Europe, with offices in New York, London and Houston. Its portfolio includes robotic medical devices, AI-enabled pathology, metabolomics, nerve regeneration and healthcare data services. Evis Hursever is CEO, Petri Vainio is Executive Chairman and Scott Barry is COO. Its public directory lists 15 current investment, operating and advisory members, with two additional managers of legacy venture funds. Operating Partners and Senior Advisors are advisory affiliations and do not by themselves establish employee or fund-partner status. Fund 1 and Fund 2 reported fully sold SEC offerings of USD543.1 million and USD746.325 million respectively; Fund 3 reported USD570.65 million sold in December 2022, without an independently verified final close. Parallel funds and former fund names are recorded within the same fund family to avoid double counting.

Founded
1985
Type
Venture capital

Funds11

  • EW Healthcare Partners Fund 3$570M

    SEC December28,2022 filing reports USD570.65 million sold, an USD800 million offering and USD229.35 million remaining. This record is a securities-sold disclosure, not a verified final-close claim. The offering and remaining totals include Fund 3-A; no separate USD800 million target or parallel-fund amount is counted as additional completed fundraising.

  • EW Healthcare Partners Acquisition Fund—

    Continuation/acquisition fund closing announced January20,2021, with Bioventus as the core holding and BlackRock-managed funds as lead investors. Financial terms were not disclosed. Acquisition of legacy holdings and LP liquidity options are distinct from a new operating-company fundraising event.

  • EW Healthcare Partners Fund 2$746M

    SEC August22,2019 filing reports USD746.325 million sold and no remaining offering, expressly aggregated across Fund 2 and Fund 2-A. The manager announced over USD745 million that day. Fund 2-A’s stated USD434 million portion is included in the combined amount, not additional capital.

  • EW Healthcare Partners Fund 1 (formerly Essex Woodlands Fund IX)$543M

    SEC October28,2016 filing reports USD543.1 million sold and no remaining offering. The filed amount expressly aggregates the issuer and a parallel partnership. Current public Fund 1 contains EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P.; former Fund IX is the same fund, recorded once. Filing date is the disclosure date.

  • Essex Woodlands Health Ventures Fund VIII$900M

    Issuer March30,2009 announcement reports USD900 million raised for Fund VIII. Its focus includes growth and venture healthcare companies. This legacy fund is distinct from former Fund IX, now EW Fund 1.

  • Essex Woodlands Health Ventures Fund II—

    Historical legacy fund expressly listed in the manager’s public LP portal. Complete fund size and exact closing date remain unverified; current asset values and individual LP commitments are not substituted for fundraising.

  • Essex Woodlands Health Ventures Fund III—

    Historical legacy fund expressly listed in the manager’s public LP portal. Complete fund size and exact closing date remain unverified; current asset values and individual LP commitments are not substituted for fundraising.

  • Essex Woodlands Health Ventures Fund IV—

    Historical legacy fund expressly listed in the manager’s public LP portal. Complete fund size and exact closing date remain unverified; current asset values and individual LP commitments are not substituted for fundraising.

Team

Operations and support

Andy ThomsonAndy ThomsonOperating Partner
Bill HawkinsBill HawkinsSenior Advisor
Bob WhiteBob WhiteOperating Partner
Bryan MortonBryan MortonOperating Partner
Evis HurseverEvis HurseverCEO
Fredrik ThorellFredrik ThorellSenior Principal
Greg HillGreg HillChief Financial Officer / Chief Compliance Officer
Guido NeelsGuido NeelsOperating Partner
Immanuel ThangarajImmanuel ThangarajManaging Director, legacy Essex Woodlands Funds IV–VIII (legacy Essex Woodlands Funds IV–VIII)
Jeff HimawanJeff HimawanManaging Director, legacy Essex Woodlands Funds VI–VIII (legacy Essex Woodlands Funds VI–VIII)
Jennifer ReissJennifer ReissVice President
Marty SutterMarty SutterFounding Partner
Petri VainioPetri VainioExecutive Chairman
Prem ChockalingamPrem ChockalingamAssociate
Ron EastmanRon EastmanSenior Advisor
Ryan ConwayRyan ConwayPrincipal
Scott BarryScott BarryCOO

Co-investing

HealthQuest Capital
Masters Special Situations
Hemanth Varghese
Madryn Asset Management
Rajiv De Silva

Investments